Integrin alpha 2b beta 3

Integrin alpha 2b beta 3 분자 정보

영어 이름Integrin alpha-IIb/beta-3시판 약물 수6
임상 약물 수7표적 별명Platelet Glycoprotein GPIIb-IIIa Complex
최고 연구 개발 단계Approved
영어 이름Integrin alpha-IIb/beta-3
표적 별명Platelet Glycoprotein GPIIb-IIIa Complex
시판 약물 수6
임상 약물 수7
최고 연구 개발 단계Approved

Integrin alpha 2b beta 3 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    His Tag (1)

  • 마커

    Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
Human
HEK293
Human Integrin alpha 2b beta 3 (ITGAIIb&ITGB3) Heterodimer Protein, His Tag&Tag Free, low endotoxin (MALS verified)
총 수량1
  • 1

Integrin alpha 2b beta 3분자 배경

Integrin alpha IIb beta 3 exist in a conformational equilibrium clustered around four main states. These conformations range from a compact bent nodule to two partially extended intermediate conformers and finally to a fully upright state. Activation of blood platelets by physiological stimuli at sites of vascular injury induces inside-out signaling, resulting in a conformational change of the prototype Integrin alpha IIb beta 3 from an inactive to an active state competent to bind soluble fibrinogen. Furthermore, ligand occupancy of Integrin alpha IIb beta 3 outside-in signaling and additional conformational changes of the receptor, leading to the exposure of extracellular neoepitopes termed ligand-induced binding sites (LIBS), which are recognized by anti-LIBS monoclonal antibodies.

Integrin alpha 2b beta 3분자 별명

Integrin alpha 2b beta 3,ITGAIIb&ITGB3

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Zalunfiban acetateRUC-4; RUC-4 acetatePhase 3 ClinicalThe Rockefeller UniversityST Elevation Myocardial Infarction
상세
18F-GPIF18-GP1; 18F-GPI; GP1-F18; GP1-18F; [18F]GP1; [18F]GP-1Phase 2 ClinicalBayer AGAortic Aneurysm, Abdominal; Venous Thrombosis
상세
MT-1002(Shaanxi Micot Technology)MT-1002Phase 2 ClinicalShaanxi Micot Pharmaceutical Technology Co LtdAcute Coronary Syndrome; Angina, Unstable; Blood Coagulation Disorders; Non-ST Elevated Myocardial Infarction; ST Elevation Myocardial Infarction; Stroke; Thrombocytopenia; Thrombosis
상세
Pury PeptideMT-1001Phase 2 ClinicalShaanxi Micot Pharmaceutical Technology Co LtdAcute Coronary Syndrome
상세
BGC-728BGC-728Phase 2 ClinicalBtg PlcMyocardial Infarction; Stroke
상세
EGT-022EG-22; HU-005; EGT-022Phase 2 ClinicalEyegene IncPressure Ulcer
상세
HYC-11395HYC-11395Phase 1 ClinicalHefei Cosource Medicine Technology, Nanjing Heqi Pharmaceutical Technology Co LtdCoronary Artery Disease; Thromboembolism
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Tirofiban Hydrochloride HydrateL-462; MK-383; MK-0383; L-700462ApprovedMerck Sharp & Dohme Corp欣维宁, 艾卡特, AggrastatUnited StatesAcute Coronary Syndrome; Coronary Thrombosis; ThrombosisMedicure Inc1998-05-14Acute Coronary Syndrome; Angina, Unstable; Cardiovascular Diseases; Cerebral Infarction; Coronary Thrombosis; Ischemic Stroke; Myocardial Infarction; Renal Insufficiency; Stroke; Subarachnoid Hemorrhage; Thrombosis; Vascular Diseases
상세
Abciximab biosimilar (ISU Abxis)ISU-301ApprovedIsu Abxis Co LtdClotinab, FaximabMyocardial Infarction; Myocardial Ischemia
상세
Abciximabc7E3-Fab; c7E3-F(ab')2ApprovedEli Lilly And Company, Johnson & Johnson Innovative MedicineReoProUnited StatesMyocardial IschemiaJanssen Biotech Inc1994-12-22Acute Disease; Angina, Unstable; Arterial Occlusive Diseases; Brain Ischemia; Carotid Stenosis; Constriction, Pathologic; Myocardial Infarction; Myocardial Ischemia; Renal Artery Obstruction; ST Elevation Myocardial Infarction; Stroke
상세
Abciximab biosimilar (Reliance Life Sciences)R-TPR-019ApprovedReliance Life SciencesAbcixiRelIndiaAngina, Unstable; Myocardial IschemiaReliance Life Sciences2013-01-01Angina, Unstable; Myocardial Ischemia
상세
EptifibatideCN-102702321; Sch-60936; SB-1; C68-22ApprovedMillennium Pharmaceuticals IncIntegrelin (former Brand Name), IntegrilinEUAngina, Unstable; Myocardial InfarctionGlaxosmithkline (Ireland) Ltd1998-05-18Acute Coronary Syndrome; Anemia, Sickle Cell; Angina, Unstable; Ischemic Stroke; Myocardial Infarction; ST Elevation Myocardial Infarction
상세
Bevifibatide CitrateBAT-2094; BAT2094ApprovedBio-Thera Solutions Ltd贝塔宁, BETAGRINMainland ChinaAcute Coronary SyndromeBio-Thera Solutions Ltd2024-06-25Acute Coronary Syndrome; Angina Pectoris; Angina, Unstable; Myocardial Infarction; Myocardial Ischemia; Non-ST Elevated Myocardial Infarction; Thrombosis
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호